Studies investigating vasomotion in the context of AD have been relatively limited; however, both enhancements27,28 and reductions29 in vasomotion have been reported in human patients, as well as impairments observed in mice expressing APOE4, a genetic risk factor for AD.30 The gene discussed is APOE; the disease is Alzheimer disease.